Fierce Biotech September 30, 2022
Every year, our Fierce Biotech team evaluates hundreds of early-stage companies from around the world. Only the most promising are selected for our annual list of Fierce 15 honorees. That list is based on a variety of factors like the strength of the company’s technology, partnerships, venture backers and competitive market position. This year’s 15 honorees were recognized at the Fierce Biotech Summit. In this episode, we’ll hear directly from them about their company’s work, what makes it unique and what drives them.
We’ll also take you to the Fierce Biotech Summit. It happened in Boston Sept. 19-20 and covered drug development from the earliest stage of research to FDA approval. So, if you missed the summit, this...
Today's Sponsors
Today's Sponsor